Parker, 25, finished 7-10 with a 4.26 ERA and 1.305 WHIP over 29 starts as a solidified piece of the 2024 rotation. But he entered 2025 spring training seemingly in a battle for the fifth starter ...
But as our student body grows, the resources that support this balance, such as our recreation center, are being pushed beyond their limits. It’s starting to feel like each visit to the rec center is ...
Assessing the quality of offerings available from Netflix in 2025, it quickly becomes clear that their horror library is a real mixed bag. As competing services, and especially genre-specific ones ...
Lilly Gerrard is preparing to welcome her first child after announcing the news last month. The daughter of Liverpool legend Steven Gerrard regularly keeps fans updated with her personal life on ...
ATTLEBORO — The city’s recreation department is starting a ... 5 to 9 p.m. this Friday in a classroom at the Pine Street center. Madison Dunphy can be reached at 508-236-0336.
Eli Lilly LLY.N plans to spend at least $27 billion to build four new manufacturing plants in the U.S., the drugmaker said at a Washington press conference on Wednesday, as it grapples with the ...
Center fielder Parker Meadows suffered a right arm injury while playing defense in Saturday's 7-6 win over the Philadelphia Phillies in the Grapefruit League opener. He reported upper arm ...
In contrast to all that, many investors prefer to focus on companies like Eli Lilly (NYSE:LLY), which has not only revenues, but also profits. While this doesn't necessarily speak to whether it's ...
WASHINGTON — Eli Lilly plans to spend $27 billion to build four new drug manufacturing sites in the United States, the company announced Wednesday, at a time when the Trump administration is ...
Eli Lilly will invest tens of billions more dollars in U.S. drug manufacturing in a significant enlargement of plans the Indianapolis company had already described as historic. Lilly, which makes the ...
Eli Lilly is buying a new drug and lowering prices on an existing one. GLP-1 weight loss drug Zepbound is getting cheaper. This will make Lilly's product relatively more attractive, and help to ...
Eli Lilly is unleashing new ammunition in its fight against cheaper, compounded versions of its obesity blockbuster Zepbound. The Indiana-based drugmaker is slashing the prices of its 2.5 mg ...